Longeveron Inc. (LGVN) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Longevron (LGVN) Q1 2026: $15.8M Cash Extends Runway as HLHS Readout Nears
  May 14, 2026
• Longevron (LGVN) Q4 2025: $15M Capital Infusion Extends Runway to Pivotal HLHS Data
  March 18, 2026
• Longevron (LGVN) Q3 2025: R&D Spend Rises 52% as HLHS Pivotal Data Nears
  November 05, 2025
• LGVN Q2 2025: R&D Spending Jumps 39% as HLHS and Pipeline Acceleration Drive Near-Term Milestones
  August 14, 2025

Browse all companies